Global Long-acting and Short-acting Oral Contraceptives Market Research Report 2024(Status and Outlook)
Report Overview:
Oral contraceptives (birth control pills) arehormone-containing medications that are taken by mouth to prevent pregnancy. They prevent pregnancy by inhibiting ovulation and also by preventing sperm from penetrating through the cervix.
The Global Long-acting and Short-acting Oral Contraceptives Market Size was estimated at USD 631.33 million in 2023 and is projected to reach USD 767.11 million by 2029, exhibiting a CAGR of 3.30% during the forecast period.
This report provides a deep insight into the global Long-acting and Short-acting Oral Contraceptives market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Long-acting and Short-acting Oral Contraceptives Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Long-acting and Short-acting Oral Contraceptives market in any manner.
Global Long-acting and Short-acting Oral Contraceptives Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer
Paladin Labs
Theramex (Teva)
Pfizer
Apotex
HRA Pharma
HLL Life Care
Mankind
Piramal
Allergan
Market Segmentation (by Type)
Combined Contraceptive Pill
Low Dose Oral Contraceptive
Market Segmentation (by Application)
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Long-acting and Short-acting Oral Contraceptives Market
- Overview of the regional outlook of the Long-acting and Short-acting Oral Contraceptives Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long-acting and Short-acting Oral Contraceptives Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Long-acting and Short-acting Oral Contraceptives
- 1.2 Key Market Segments
- 1.2.1 Long-acting and Short-acting Oral Contraceptives Segment by Type
- 1.2.2 Long-acting and Short-acting Oral Contraceptives Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Long-acting and Short-acting Oral Contraceptives Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Long-acting and Short-acting Oral Contraceptives Market Size (M USD) Estimates and Forecasts (2019-2030)
- 2.1.2 Global Long-acting and Short-acting Oral Contraceptives Sales Estimates and Forecasts (2019-2030)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Long-acting and Short-acting Oral Contraceptives Market Competitive Landscape
- 3.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Manufacturers (2019-2024)
- 3.2 Global Long-acting and Short-acting Oral Contraceptives Revenue Market Share by Manufacturers (2019-2024)
- 3.3 Long-acting and Short-acting Oral Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Long-acting and Short-acting Oral Contraceptives Average Price by Manufacturers (2019-2024)
- 3.5 Manufacturers Long-acting and Short-acting Oral Contraceptives Sales Sites, Area Served, Product Type
- 3.6 Long-acting and Short-acting Oral Contraceptives Market Competitive Situation and Trends
- 3.6.1 Long-acting and Short-acting Oral Contraceptives Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Long-acting and Short-acting Oral Contraceptives Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Long-acting and Short-acting Oral Contraceptives Industry Chain Analysis
- 4.1 Long-acting and Short-acting Oral Contraceptives Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Long-acting and Short-acting Oral Contraceptives Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Long-acting and Short-acting Oral Contraceptives Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Type (2019-2024)
- 6.3 Global Long-acting and Short-acting Oral Contraceptives Market Size Market Share by Type (2019-2024)
- 6.4 Global Long-acting and Short-acting Oral Contraceptives Price by Type (2019-2024)
- 7 Long-acting and Short-acting Oral Contraceptives Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Long-acting and Short-acting Oral Contraceptives Market Sales by Application (2019-2024)
- 7.3 Global Long-acting and Short-acting Oral Contraceptives Market Size (M USD) by Application (2019-2024)
- 7.4 Global Long-acting and Short-acting Oral Contraceptives Sales Growth Rate by Application (2019-2024)
- 8 Long-acting and Short-acting Oral Contraceptives Market Segmentation by Region
- 8.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Region
- 8.1.1 Global Long-acting and Short-acting Oral Contraceptives Sales by Region
- 8.1.2 Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Long-acting and Short-acting Oral Contraceptives Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Long-acting and Short-acting Oral Contraceptives Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Long-acting and Short-acting Oral Contraceptives Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Long-acting and Short-acting Oral Contraceptives Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Bayer
- 9.1.1 Bayer Long-acting and Short-acting Oral Contraceptives Basic Information
- 9.1.2 Bayer Long-acting and Short-acting Oral Contraceptives Product Overview
- 9.1.3 Bayer Long-acting and Short-acting Oral Contraceptives Product Market Performance
- 9.1.4 Bayer Business Overview
- 9.1.5 Bayer Long-acting and Short-acting Oral Contraceptives SWOT Analysis
- 9.1.6 Bayer Recent Developments
- 9.2 Paladin Labs
- 9.2.1 Paladin Labs Long-acting and Short-acting Oral Contraceptives Basic Information
- 9.2.2 Paladin Labs Long-acting and Short-acting Oral Contraceptives Product Overview
- 9.2.3 Paladin Labs Long-acting and Short-acting Oral Contraceptives Product Market Performance
- 9.2.4 Paladin Labs Business Overview
- 9.2.5 Paladin Labs Long-acting and Short-acting Oral Contraceptives SWOT Analysis
- 9.2.6 Paladin Labs Recent Developments
- 9.3 Theramex (Teva)
- 9.3.1 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Basic Information
- 9.3.2 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product Overview
- 9.3.3 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product Market Performance
- 9.3.4 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives SWOT Analysis
- 9.3.5 Theramex (Teva) Business Overview
- 9.3.6 Theramex (Teva) Recent Developments
- 9.4 Pfizer
- 9.4.1 Pfizer Long-acting and Short-acting Oral Contraceptives Basic Information
- 9.4.2 Pfizer Long-acting and Short-acting Oral Contraceptives Product Overview
- 9.4.3 Pfizer Long-acting and Short-acting Oral Contraceptives Product Market Performance
- 9.4.4 Pfizer Business Overview
- 9.4.5 Pfizer Recent Developments
- 9.5 Apotex
- 9.5.1 Apotex Long-acting and Short-acting Oral Contraceptives Basic Information
- 9.5.2 Apotex Long-acting and Short-acting Oral Contraceptives Product Overview
- 9.5.3 Apotex Long-acting and Short-acting Oral Contraceptives Product Market Performance
- 9.5.4 Apotex Business Overview
- 9.5.5 Apotex Recent Developments
- 9.6 HRA Pharma
- 9.6.1 HRA Pharma Long-acting and Short-acting Oral Contraceptives Basic Information
- 9.6.2 HRA Pharma Long-acting and Short-acting Oral Contraceptives Product Overview
- 9.6.3 HRA Pharma Long-acting and Short-acting Oral Contraceptives Product Market Performance
- 9.6.4 HRA Pharma Business Overview
- 9.6.5 HRA Pharma Recent Developments
- 9.7 HLL Life Care
- 9.7.1 HLL Life Care Long-acting and Short-acting Oral Contraceptives Basic Information
- 9.7.2 HLL Life Care Long-acting and Short-acting Oral Contraceptives Product Overview
- 9.7.3 HLL Life Care Long-acting and Short-acting Oral Contraceptives Product Market Performance
- 9.7.4 HLL Life Care Business Overview
- 9.7.5 HLL Life Care Recent Developments
- 9.8 Mankind
- 9.8.1 Mankind Long-acting and Short-acting Oral Contraceptives Basic Information
- 9.8.2 Mankind Long-acting and Short-acting Oral Contraceptives Product Overview
- 9.8.3 Mankind Long-acting and Short-acting Oral Contraceptives Product Market Performance
- 9.8.4 Mankind Business Overview
- 9.8.5 Mankind Recent Developments
- 9.9 Piramal
- 9.9.1 Piramal Long-acting and Short-acting Oral Contraceptives Basic Information
- 9.9.2 Piramal Long-acting and Short-acting Oral Contraceptives Product Overview
- 9.9.3 Piramal Long-acting and Short-acting Oral Contraceptives Product Market Performance
- 9.9.4 Piramal Business Overview
- 9.9.5 Piramal Recent Developments
- 9.10 Allergan
- 9.10.1 Allergan Long-acting and Short-acting Oral Contraceptives Basic Information
- 9.10.2 Allergan Long-acting and Short-acting Oral Contraceptives Product Overview
- 9.10.3 Allergan Long-acting and Short-acting Oral Contraceptives Product Market Performance
- 9.10.4 Allergan Business Overview
- 9.10.5 Allergan Recent Developments
- 10 Long-acting and Short-acting Oral Contraceptives Market Forecast by Region
- 10.1 Global Long-acting and Short-acting Oral Contraceptives Market Size Forecast
- 10.2 Global Long-acting and Short-acting Oral Contraceptives Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Country
- 10.2.3 Asia Pacific Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Region
- 10.2.4 South America Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Long-acting and Short-acting Oral Contraceptives by Country
- 11 Forecast Market by Type and by Application (2025-2030)
- 11.1 Global Long-acting and Short-acting Oral Contraceptives Market Forecast by Type (2025-2030)
- 11.1.1 Global Forecasted Sales of Long-acting and Short-acting Oral Contraceptives by Type (2025-2030)
- 11.1.2 Global Long-acting and Short-acting Oral Contraceptives Market Size Forecast by Type (2025-2030)
- 11.1.3 Global Forecasted Price of Long-acting and Short-acting Oral Contraceptives by Type (2025-2030)
- 11.2 Global Long-acting and Short-acting Oral Contraceptives Market Forecast by Application (2025-2030)
- 11.2.1 Global Long-acting and Short-acting Oral Contraceptives Sales (Kilotons) Forecast by Application
- 11.2.2 Global Long-acting and Short-acting Oral Contraceptives Market Size (M USD) Forecast by Application (2025-2030)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook